NCT07225270
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07225270
Title Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy (RAINFOL-04)
Acronym RAINFOL-04
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Genmab
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.